ACOT11 and gastric cancer: Further RIP assays confirmed the interaction between miR-1343-3p and ACOT11, indicating that salidroside likely inhibits GC cell proliferation by down-regulating ACOT11 through miR-1343-3p targeting, thereby interfering with lipid metabolism and energy production.